Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FSG09
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,441
Award facts
- Contract value 100% obligated
- $10,440.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,440.68 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract, awarded on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed price delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the contractor to supply a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
Repatha is a PCSK9 inhibitor used in the treatment of high cholesterol and cardiovascular disease prevention, representing a specialized pharmaceutical commodity within the broader military healthcare supply chain. AmerisourceBergen's status as a major pharmaceutical distributor and critical vendor for federal medical procurement, combined with its competitive award track record through the DLA Medical Supply Chain, demonstrates the company's capability to fulfill specialized pharmaceutical requirements. This transaction exemplifies the Defense Logistics Agency's ongoing procurement of brand-name specialty medications to support military personnel and veteran healthcare systems globally.
Quick answers
Who was awarded contract SPE2DB25FSG09?
SPE2DB25FSG09 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FSG09 worth?
The government has obligated $10,441 on SPE2DB25FSG09.
Is contract SPE2DB25FSG09 an order under another contract?
Yes. SPE2DB25FSG09 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FSG09 competed?
The extent of competition for SPE2DB25FSG09 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award